Apex Biotechnology Corp. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was TWD 417.28 million compared to TWD 608.11 million a year ago. Net income was TWD 27.02 million compared to TWD 29.06 million a year ago. Basic earnings per share from continuing operations was TWD 0.27 compared to TWD 0.29 a year ago. Diluted earnings per share from continuing operations was TWD 0.27 compared to TWD 0.29 a year ago.
For the six months, sales was TWD 853.82 million compared to TWD 1,130.06 million a year ago. Net income was TWD 62.75 million compared to TWD 74.65 million a year ago. Basic earnings per share from continuing operations was TWD 0.63 compared to TWD 0.75 a year ago. Diluted earnings per share from continuing operations was TWD 0.63 compared to TWD 0.74 a year ago.